Baader Bank Aktiengesellschaft Makes New Investment in Organigram Global Inc. $OGI

Key Points

• Baader Bank Aktiengesellschaft made a new investment in Organigram Global Inc. by acquiring 250,644 shares valued at approximately $338,000.
• Organigram's recent earnings report showed a loss of ($0.03) per share, missing estimates, with quarterly revenue totaling $50.49 million.
• Institutional investors own 34.63% of Organigram, indicating significant interest, though Wall Street analysts recently downgraded the stock from a "hold" to a "sell" rating.

Baader Bank Aktiengesellschaft bought a new stake in shares of Organigram Global Inc. (NASDAQ:OGI - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 250,644 shares of the company's stock, valued at approximately $338,000. Baader Bank Aktiengesellschaft owned approximately 0.19% of Organigram Global as of its most recent SEC filing.

Separately, Wealth Enhancement Advisory Services LLC acquired a new position in shares of Organigram Global in the 1st quarter valued at $30,000. 34.63% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Wall Street Zen lowered Organigram Global from a "hold" rating to a "sell" rating in a research report on Saturday, August 16th.

Organigram Global Price Performance

Shares of OGI stock traded up $0.03 during trading on Tuesday, reaching $1.82. The company had a trading volume of 194,015 shares, compared to its average volume of 722,898. The firm's 50 day simple moving average is $1.57 and its two-hundred day simple moving average is $1.33. Organigram Global Inc. has a one year low of $0.85 and a one year high of $1.94. The company has a market capitalization of $243.83 million, a PE ratio of 36.31 and a beta of 1.49.

Organigram Global (NASDAQ:OGI - Get Free Report) last issued its quarterly earnings data on Wednesday, August 13th. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.02). Organigram Global had a net margin of 2.86% and a negative return on equity of 8.19%. The company had revenue of $50.49 million during the quarter, compared to the consensus estimate of $68.04 million. Analysts forecast that Organigram Global Inc. will post -0.19 earnings per share for the current year.

About Organigram Global

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.